What is the long-term trend for Journey Medical Corporation's other commercial liabilities?

Over 5 years (2020 to 2025), Journey Medical Corporation's other commercial liabilities has grown at a 5.1% compound annual growth rate (CAGR), from $21.5M to $27.57M.

Journey Medical Corporation DERM Other Commercial Liabilities

Other Commercial Liabilities at other companies

Bausch Health CompaniesBHC

——

PTH

Pelthos Therapeutics Inc.PTHS

——

Arcutis Biotherapeutics, Inc.ARQT

——

Catalyst PharmaceuticalCPRX

——

VAT

InnovateVATE

——

Pulse Biosciences, Inc.PLSE

——

Other financials

Income statement

See full

Revenue$16.0M+21.5%

Gross profit$9.7M+16.7%

Operating income-$1.5M+55.1%

Net income-$2.2M+45.2%

EPS (diluted)-$0.08+55.6%

Balance sheet

See full

Cash & equivalents$27.2M+29.2%

Total debt$25.5M+1.2%

Total equity$30.8M+43.1%

Total assets$91.5M+7.7%

Cash flow

See full

Operating cash flow$2.9M+203%

CapEx$3.8M—

Free cash flow-$6.0M—

Valuation

See full

Market cap$194.94M+20.9%

Enterprise value$193.19M+16.2%

P/S3×+0.2×

Profitability

See full

Gross margin65.4%-1.0pp

Operating margin-9.8%—

Net margin-14.8%—

FCF margin-43%—

Returns & leverage

See full

Return on equity-36.6%—

Debt / equity0.8×-0.3×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Journey Medical Corporation's other commercial liabilities?: Journey Medical Corporation (DERM) reported other commercial liabilities of $26.1M in Q1 2026.
How has Journey Medical Corporation's other commercial liabilities changed year-over-year?: Journey Medical Corporation's other commercial liabilities increased by 13.4% year-over-year, from $23.01M to $26.1M.
What is the long-term trend for Journey Medical Corporation's other commercial liabilities?: Over 5 years (2020 to 2025), Journey Medical Corporation's other commercial liabilities has grown at a 5.1% compound annual growth rate (CAGR), from $21.5M to $27.57M.